Cambridge Innovation Capital
Status
ACTIVE
Global HQ
Cambridge, United Kingdom
Countries of investment
- United Kingdom
Investment stages
- Seed
- Series A
- Series B
Industries
- Biotechnology
- MedTech
- Deep Tech
About
Cambridge Innovation Capital (CIC) is deeply embedded within the Cambridge ecosystem, providing funding and support to deep-tech and life-science startups that have the potential to become global leaders. With a focus on cutting-edge industries such as AI, quantum computing, semiconductors, and biotechnology, CIC partners with leading academic institutions to identify high-potential startups. The firm not only provides capital but also helps these ventures navigate the complexities of scaling operations, hiring top talent, and establishing governance frameworks to reach international markets.
Cambridge Innovation Capital (CIC) is deeply embedded within the Cambridge ecosystem, providing funding and support to deep-tech and life-science startups that have the potential to become global leaders. With a focus on cutting-edge industries such as AI, quantum computing, semiconductors, and biotechnology, CIC partners with leading academic institutions to identify high-potential startups. The firm not only provides capital but also helps these ventures navigate the complexities of scaling operations, hiring top talent, and establishing governance frameworks to reach international markets.
Investment Thesis
Cambridge Innovation Capital backs deep-tech and life-science ventures emerging from the Cambridge ecosystem, investing in founders and technologies that leverage the region’s world-class research base. Its thesis centers on scaling transformative innovations in AI, quantum, semiconductors, and biotech into globally competitive companies. CIC bridges academia and industry by providing long-term patient capital and active strategic guidance to accelerate commercialization.
Manager's Experience
Led by professionals with extensive experience in deep tech and healthcare, focused on scaling university spinouts and science-led businesses.
Team
Andrew Williamson – Managing Partner
Anne Horgan – Partner
Ian Lane – Partner
Adam Glinsman – Not Available
Tom Page – Head of IR.
Portfolio
Pragmatic Semiconductor
Riverlane
Starhawk
PASTx
Ceres Power
StormBios
Chroma Therapeutics
Blue Earth
Harness
Escientia